Scoping Review: Penggunaan Hidroksiklorokuin Pada Pengobatan Covid-19

Yerlina (2020) Scoping Review: Penggunaan Hidroksiklorokuin Pada Pengobatan Covid-19. Thesis thesis, UNIVERSITAS AIRLANGGA.

[img] Text (HALAMAN JUDUL)
1. HALAMAN JUDUL.pdf

Download (694kB)
[img] Text (ABSTRACT)
2. ABSTRACT.pdf

Download (88kB)
[img] Text (DAFTAR ISI)
3. DAFTAR ISI.pdf

Download (88kB)
[img] Text (BAB I)
4. BAB I PENDAHULUAN.pdf

Download (103kB)
[img] Text (BAB II)
5. BAB II TINJAUAN PUSTAKA.pdf
Restricted to Registered users only until 15 December 2023.

Download (279kB) | Request a copy
[img] Text (BAB III)
6. BAB III KERANGKA KONSEPTUAL.pdf
Restricted to Registered users only until 15 December 2023.

Download (90kB) | Request a copy
[img] Text (BAB IV)
7. BAB IV METODE PENELITIAN .pdf
Restricted to Registered users only until 15 December 2023.

Download (116kB) | Request a copy
[img] Text (BAB V)
8. BAB V HASIL.pdf
Restricted to Registered users only until 15 December 2023.

Download (95kB) | Request a copy
[img] Text (BAB VI)
9. BAB VI PEMBAHASAN.pdf
Restricted to Registered users only until 15 December 2023.

Download (143kB) | Request a copy
[img] Text (BAB VII)
10. BAB VII KESIMPULAN DAN SARAN.pdf
Restricted to Registered users only until 15 December 2023.

Download (44kB) | Request a copy
[img] Text (DAFTAR PUSTAKA)
11. DAFTAR PUSTAKA.pdf

Download (207kB)
[img] Text (KESEDIAAN)
12. Kesediaan Publikasi Yerlina Virgia.pdf
Restricted to Registered users only

Download (95kB) | Request a copy
Official URL: http://lib.unair.ac.id

Abstract

BACKGROUND – COVID-19 is declared a pandemic of international concern. Coronavirus infection has rapidly spread throughout the world and has infected more than 210 countries worldwide. Until now, there has been no approved specific treatment for COVID-19 or a vaccine to prevent coronavirus infection. Hydroxychloroquine has received attention as a potential therapeutic agent against COVID-19. OBJECTIVE – To analyze and summarize the evidence related to the use of hydroxychloroquine in the treatment of COVID-19. METHOD – The research method is an electronic literature search using the PubMed database and Science Direct. The literature included in the search criteria was literature published from December 2019 to June 19, 2020. The literature obtained was extracted and analyzed critically. RESULTS – A total of 4231 articles were screened, and six kinds of literature that match the inclusion criteria were obtained for a total sample of 3434 patients. Several studies have shown good virological. The clinical results are using hydroxychloroquine therapy with or without azithromycin and a relatively small risk of side effects. And the other studies have shown unfavorable results using hydroxychloroquine therapy. CONCLUSIONS – The use of hydroxychloroquine with azithromycin can be used as a short-term solution for alternative therapies to overcome the COVID-19 pandemic with close monitoring for side effects. A randomized clinical study with a rigorous methodological design is needed to minimize the risk of bias and better validity regarding the evidence of the effectiveness and safety of using hydroxychloroquine in the treatment of COVID-19.

Item Type: Thesis (Thesis)
Additional Information: KKC KK TFK.12-20 Yer s
Uncontrolled Keywords: COVID-19, coronavirus, hydroxychloroquine, azithromycin.
Subjects: R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica
Divisions: 05. Fakultas Farmasi > Farmasi Klinis
Creators:
CreatorsNIM
YerlinaNIM051815153027
Contributors:
ContributionNameNIDN / NIDK
Thesis advisorDidik HasmonoNIDN0011095807
Thesis advisorArief Wijaya Rosli-
Thesis advisorDewi Ramdani-
Depositing User: Tatik Poedjijarti
Date Deposited: 15 Dec 2020 04:18
Last Modified: 15 Dec 2020 04:18
URI: http://repository.unair.ac.id/id/eprint/101679
Sosial Share:

Actions (login required)

View Item View Item